These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27256607)

  • 1. [An evaluation of plasma aldosterone-to-active-renin ratio in different postures in combination with aldosterone concentration in the diagnosis of aldosteronoma].
    Zhu J; Jin N; Zang L; Gu WJ; Yang GQ; Yang LJ; Guo QH; Wang XL; Lyu ZH; Ba JM; Dou JT; Mu YM
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):451-4. PubMed ID: 27256607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of characteristics of renin, aldosterone and aldosterone/renin ratio in patients with aldosterone-producing adenoma].
    He YB; Yu X; Zhou XR; Shu BH; Liu JH
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3379-83. PubMed ID: 24418036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the ratio of plasma aldosterone to rennin concentration measured by an automated chemiluminescent immunoassay in screening for primary aldosteronism].
    Song Y; He W; Yang S; Cheng Q; Hu J; Zhen Q; Long J; Feng Z; Li R; Wang Z; Ren W; Zhou B; Li Q
    Zhonghua Nei Ke Za Zhi; 2016 Jan; 55(1):6-10. PubMed ID: 26796645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
    [No Abstract]   [Full Text] [Related]  

  • 6. One-hour upright posture is an ideal position for serum aldosterone concentration and plasma renin activity measuring on primary aldosteronism screening.
    Yin G; Zhang S; Yan L; Wu M; Xu M; Li F; Cheng H
    Exp Clin Endocrinol Diabetes; 2012 Jul; 120(7):388-94. PubMed ID: 22689101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of postural changes on aldosterone to plasma renin ratio in patients with suspected secondary hypertension.
    Barigou M; Ah-Kang F; Orloff E; Amar J; Chamontin B; Bouhanick B
    Ann Cardiol Angeiol (Paris); 2015 Jun; 64(3):169-74. PubMed ID: 26051856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension.
    Lonati C; Bassani N; Gritti A; Biganzoli E; Morganti A
    J Hypertens; 2014 Mar; 32(3):627-34. PubMed ID: 24445391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
    Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
    J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical validation and investigation on reference intervals of aldosterone and renin in Chinese Han population by using fully automated chemiluminescence immunoassays.
    Deng L; Xiong Z; Li H; Lei X; Cheng L
    Clin Biochem; 2018 Jun; 56():89-94. PubMed ID: 29684370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration.
    Baron S; Amar L; Faucon AL; Blanchard A; Baffalie L; Faucard C; Travers S; Pagny JY; Azizi M; Houillier P
    J Hypertens; 2018 Jul; 36(7):1592-1601. PubMed ID: 29677048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of Screening and Confirmatory Tests of Primary Aldosteronism in Diagnosing Aldosterone Producing Adenoma].
    Hu FQ; Huang J; Huang H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 May; 49(3):469-473. PubMed ID: 30014653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of primary aldosteronism: comparison of post-captopril active renin concentration and plasma renin activity.
    Wu VC; Kuo CC; Chang HW; Tsai CT; Lin CY; Lin LY; Lin YH; Wang SM; Huang KH; Fang CC; Ho YL; Liu KL; Chang CC; Chueh SC; Lin SL; Yen RF; Wu KD;
    Clin Chim Acta; 2010 May; 411(9-10):657-63. PubMed ID: 20117105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.
    Ferrari P; Shaw SG; Nicod J; Saner E; Nussberger J
    J Hypertens; 2004 Feb; 22(2):377-81. PubMed ID: 15076197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays.
    Manolopoulou J; Fischer E; Dietz A; Diederich S; Holmes D; Junnila R; Grimminger P; Reincke M; Morganti A; Bidlingmaier M
    J Hypertens; 2015 Dec; 33(12):2500-11. PubMed ID: 26372319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased plasma prorenin levels in primary aldosteronism: potential diagnostic implications.
    Berge C; Courand PY; Harbaoui B; Paget V; Khettab F; Bricca G; Fauvel JP; Lantelme P
    J Hypertens; 2015 Jan; 33(1):118-25. PubMed ID: 25333683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone-to-renin ratio for diagnosing aldosterone-producing adenoma: a multicentre study.
    Ducher M; Mounier-Véhier C; Baguet JP; Tartière JM; Sosner P; Régnier-Le Coz S; Perez L; Fourcade J; Jabourek O; Lejeune S; Stolz A; Fauvel JP
    Arch Cardiovasc Dis; 2012 Dec; 105(12):623-30. PubMed ID: 23199617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of confirmatory test results for the diagnosis of primary hyperaldosteronism in hypertensive patients with an aldosterone-to-renin ratio greater than 20. The SHRIMP study.
    Okamoto R; Taniguchi M; Onishi Y; Kumagai N; Uraki J; Fujimoto N; Fujii E; Yano Y; Ogura T; Ito M
    Hypertens Res; 2019 Jan; 42(1):40-51. PubMed ID: 30401909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of plasma aldosterone and renin data between an automated chemiluminescent immunoanalyzer and conventional radioimmunoassays in the screening and diagnosis of primary aldosteronism.
    Tamura N; Watanabe E; Shirakawa R; Nakatani E; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Ogawa T; Kotani M; Usui T; Inoue T
    PLoS One; 2021; 16(7):e0253807. PubMed ID: 34242264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism.
    Burrello J; Monticone S; Buffolo F; Lucchiari M; Tetti M; Rabbia F; Mengozzi G; Williams TA; Veglio F; Mulatero P
    J Hypertens; 2016 May; 34(5):920-7. PubMed ID: 27031933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.